It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Knowledge of genomic features specific to the human lineage may provide insights into brain-related diseases. We leverage high-depth whole genome sequencing data to generate a combined annotation identifying regions simultaneously depleted for genetic variation (constrained regions) and poorly conserved across primates. We propose that these constrained, non-conserved regions (CNCRs) have been subject to human-specific purifying selection and are enriched for brain-specific elements. We find that CNCRs are depleted from protein-coding genes but enriched within lncRNAs. We demonstrate that per-SNP heritability of a range of brain-relevant phenotypes are enriched within CNCRs. We find that genes implicated in neurological diseases have high CNCR density, including APOE, highlighting an unannotated intron-3 retention event. Using human brain RNA-sequencing data, we show the intron-3-retaining transcript to be more abundant in Alzheimer’s disease with more severe tau and amyloid pathological burden. Thus, we demonstrate potential association of human-lineage-specific sequences in brain development and neurological disease.
Knowledge of genomic features specific to humans may be important for understanding disease. Here the authors demonstrate a potential role for these human-lineage-specific sequences in brain development and neurological disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University College London (UCL), Department of Neurodegenerative Disease, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); University College London, NIHR Great Ormond Street Hospital Biomedical Research Centre, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); University College London, Department of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
2 University College London (UCL), Department of Neurodegenerative Disease, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
3 Queen Mary University of London, Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133); University College London (UCL), Department of Molecular Neuroscience, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
4 University College London (UCL), Department of Molecular Neuroscience, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
5 University of Liverpool, Institute of Translational Medicine, Liverpool, UK (GRID:grid.10025.36) (ISNI:0000 0004 1936 8470)
6 University College London (UCL), Department of Clinical and Movement Neuroscience, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
7 MRC Centre for Neuropsychiatric Genetics & Genomics, Biostatistics & Bioinformatics Unit, Institute of Psychological Medicine and Clinical Neuroscience, Cardiff, UK (GRID:grid.83440.3b)
8 University College London (UCL), Department of Molecular Neuroscience, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); King Faisal Specialist Hospital and Research Centre, Department of Genetics, Riyadh, Saudi Arabia (GRID:grid.415310.2) (ISNI:0000 0001 2191 4301)
9 University College London, Department of Genetics and Genomic Medicine, Great Ormond Street Institute of Child Health, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); University College London (UCL), Department of Molecular Neuroscience, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
10 University College London (UCL), Institute of Healthy Ageing, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
11 University of Reading, Reading, UK (GRID:grid.9435.b) (ISNI:0000 0004 0457 9566)
12 University College London (UCL), Department of Molecular Neuroscience, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); University College London (UCL), UK Dementia Research Institute, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
13 University College London (UCL), Institute of Cardiovascular Science, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
14 Cardiff University School of Medicine, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff, UK (GRID:grid.5600.3) (ISNI:0000 0001 0807 5670)
15 Institut du Cerveau et de la Moelle épinière, ICM, Inserm U 1127, CNRS, UMR 7225, Sorbonne Universités, UPMC University Paris 06, UMR S 1127, AP-HP, Pitié-Salpêtrière Hospital, Paris, France (GRID:grid.5600.3)
16 Institut du Cerveau et de la Moelle épinière, ICM, Inserm U 1127, CNRS, UMR 7225, Sorbonne Universités, UPMC University Paris 06, UMR S 1127, Centre d’Investigation Clinique Pitié Neurosciences CIC-1422, AP-HP, Pitié-Salpêtrière Hospital, Paris, France (GRID:grid.5600.3)
17 INSERM UMR 1220 and Paul Sabatier University, Toulouse, France (GRID:grid.15781.3a) (ISNI:0000 0001 0723 035X)
18 University of Tübingen, Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, German Center for Neurodegenerative Diseases, DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
19 University of Tubingen, Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
20 Laboratory of Neurogenetics, National Institute on Aging, Bethesda, USA (GRID:grid.419475.a) (ISNI:0000 0000 9372 4913)
21 Laboratory of Neurogenetics, National Institute on Aging, Bethesda, USA (GRID:grid.419475.a) (ISNI:0000 0000 9372 4913); National Institute of Neurological Disorders and Stroke, Bethesda, USA (GRID:grid.416870.c) (ISNI:0000 0001 2177 357X)
22 University of Southern California, Department of Translational Genomics, Keck School of Medicine, Los Angeles, USA (GRID:grid.42505.36) (ISNI:0000 0001 2156 6853)
23 Laboratory of Neurogenetics, National Institute on Aging, Bethesda, USA (GRID:grid.419475.a) (ISNI:0000 0000 9372 4913); University of Illinois at Urbana-Champaign, Department of Computer Science, Urbana, USA (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991)
24 TGen, Neurogenomics Division, Phoenix, USA (GRID:grid.250942.8) (ISNI:0000 0004 0507 3225)
25 Baylor College of Medicine, Departments of Neurology, Neuroscience, and Molecular & Human Genetics, Houston, USA (GRID:grid.39382.33) (ISNI:0000 0001 2160 926X); Texas Children’s Hospital, Jan and Dan Duncan Neurological Research Institute, Houston, USA (GRID:grid.416975.8) (ISNI:0000 0001 2200 2638)
26 Laboratory of Neurogenetics, National Institute on Aging, Bethesda, USA (GRID:grid.419475.a) (ISNI:0000 0000 9372 4913); Data Tecnica International, Glen Echo, USA (GRID:grid.419475.a)
27 Northwestern University Feinberg School of Medicine, Ken and Ruth Davee Department of Neurology, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)
28 University of California, Department of Neurology and Physiology, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); Gladstone Institute of Neurological Disease, San Francisco, USA (GRID:grid.249878.8) (ISNI:0000 0004 0572 7110); Taube/Koret Center for Neurodegenerative Disease Research, San Francisco, USA (GRID:grid.497581.6)
29 Northwestern University Feinberg School of Medicine, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)
30 National Institutes of Health, National Institutes of Health Division of Clinical Research, NINDS, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165)
31 National Institute of Neurological Disorders and Stroke, Neurodegenerative Diseases Research Unit, Bethesda, USA (GRID:grid.416870.c) (ISNI:0000 0001 2177 357X)
32 Columbia University Medical Center, Department of Neurology, College of Physicians and Surgeons, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675); Columbia University Medical Center, Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, College of Physicians and Surgeons, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675)
33 McGill University, Montreal Neurological Institute and Hospital, Department of Neurology & Neurosurgery, Department of Human Genetics, Montréal, Canada (GRID:grid.14709.3b) (ISNI:0000 0004 1936 8649)
34 Leiden University Medical Center, Department of Neurology, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978)
35 Instituto de Biomedicina de Sevilla Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922)
36 University Hospital Mutua de Terrassa, Fundació Docència I Recerca Mútua de Terrassa and Movement Disorders Unit, Department of Neurology, Terrassa, Spain (GRID:grid.414875.b) (ISNI:0000 0004 1794 4956)
37 Hospital Universitario Central de Asturias, Oviedo, Spain (GRID:grid.411052.3) (ISNI:0000 0001 2176 9028)
38 Universidad de Granada, Hospital Universitario San Cecilio de Granada, Granada, Spain (GRID:grid.4489.1) (ISNI:0000000121678994)
39 Instituto de Investigación Sanitaria Biodonostia, San Sebastián, Spain (GRID:grid.432380.e)
40 Hospital Clinic de Barcelona, Barcelona, Spain (GRID:grid.410458.c) (ISNI:0000 0000 9635 9413)
41 UCL, Department of Neuromuscular Disease, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
42 Hospital General de Segovia, Segovia, Spain (GRID:grid.415456.7) (ISNI:0000 0004 0630 5358)
43 Universitat Autònoma de Barcelona, Memory Unit, Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain (GRID:grid.7080.f); Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
44 Universidad de Granada, Centro de Investigacion Biomedica, Granada, Spain (GRID:grid.4489.1) (ISNI:0000000121678994)
45 Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria de Granada, Granada, Spain (GRID:grid.411380.f) (ISNI:0000 0000 8771 3783)
46 Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Hospital Universitario Marqués de Valdecilla-IDIVALS, Madrid, Spain (GRID:grid.5515.4) (ISNI:0000000119578126)
47 Hospital Universitario Virgen de la Victoria, Malaga, Spain (GRID:grid.411062.0) (ISNI:0000 0000 9788 2492)
48 Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Spain (GRID:grid.411325.0) (ISNI:0000 0001 0627 4262)
49 Institut de Recerca Sant Joan de Déu, Terrassa, Spain (GRID:grid.432380.e)
50 Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Hospital Universitario Ramón y Cajal, Madrid, Spain (GRID:grid.411347.4) (ISNI:0000 0000 9248 5770)
51 Hospital Universitario Ramón y Cajal, Madrid, Spain (GRID:grid.411347.4) (ISNI:0000 0000 9248 5770)
52 Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Universitat Autònoma de Barcelona, Movement Disorders Unit, Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Terrassa, Spain (GRID:grid.7080.f)
53 Hospital Universitario y Politécnico La Fe, Department of Neurology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain (GRID:grid.84393.35) (ISNI:0000 0001 0360 9602)
54 Hospital Universitario Infanta Sofía, Department of Neurology, Madrid, Spain (GRID:grid.414758.b) (ISNI:0000 0004 1759 6533)
55 Universitat Autònoma de Barcelona, Movement Disorders Unit, Department of Neurology, IIB Sant Pau, Hospital de la Santa Creu i Sant Pau, Terrassa, Spain (GRID:grid.7080.f)
56 Instituto de Investigación Sanitaria Biodonostia, Hospital Universitario Donostia, San Sebastián, Spain (GRID:grid.432380.e)
57 University Hospital Mutua de Terrassa, Fundació Docència i Recerca Mútua de Terrassa and Movement Disorders Unit, Department of Neurology, Terrassa, Spain (GRID:grid.414875.b) (ISNI:0000 0004 1794 4956)
58 Hospital Universitario Fundación Alcorcón, Department of Neurology, Madrid, Spain (GRID:grid.411316.0) (ISNI:0000 0004 1767 1089)
59 Medical University of Vienna, Department of Neurology, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492)
60 Oslo University Hospital, Department of Neurology, Oslo, Norway (GRID:grid.55325.34) (ISNI:0000 0004 0389 8485)
61 University of Tartu, Department of Pathophysiology, Tartu, Estonia (GRID:grid.10939.32) (ISNI:0000 0001 0943 7661); Estonian University of Life Sciences, Department of Reproductive Biology, Tartu, Estonia (GRID:grid.16697.3f) (ISNI:0000 0001 0671 1127)
62 University of Tartu, Department of Neurology and Neurosurgery, Tartu, Estonia (GRID:grid.10939.32) (ISNI:0000 0001 0943 7661)
63 Chaim Sheba Medical Center, Movement Disorders Institute, Department of Neurology and Sagol Neuroscience Center, Ramat Gan, Israel (GRID:grid.413795.d) (ISNI:0000 0001 2107 2845); Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546)
64 University College London (UCL), Department of Neurodegenerative Disease, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); Queen Square Institute of Neurology, UCL, Reta Lila Weston Institute, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); UCL, UK Dementia Research Institute, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); NIHR University College London Hospitals Biomedical Research Centre, London, UK (GRID:grid.451056.3) (ISNI:0000 0001 2116 3923); The Hong Kong University of Science and Technology, Institute for Advanced Study, The Hong Kong University of Science and Technology, Hong Kong SAR, China (GRID:grid.24515.37) (ISNI:0000 0004 1937 1450)
65 Université de Montréal, Department of Medicine & Department of Neurosciences, Université de Montréal, Montréal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357); Montréal Heart Institute, Montréal, Québec, Canada (GRID:grid.482476.b) (ISNI:0000 0000 8995 9090)
66 University College London (UCL), Department of Neurodegenerative Disease, Queen Square Institute of Neurology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201); Universidad de Murcia, Departamento de Ingeniería de la Información y las Comunicaciones, Murcia, Spain (GRID:grid.10586.3a) (ISNI:0000 0001 2287 8496)